Bioreactors get personal
Adoptive cell transfer immunotherapy against melanoma is highly effective. However, this therapy has seen limited dissemination, mainly due to the complexity and costs of cell expansion protocols. Two bioreactors have recently been described that simplify and streamline the production of individuali...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Landes Bioscience
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518529/ |
| id |
pubmed-3518529 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-35185292012-12-14 Bioreactors get personal Somerville, Robert P.T. Dudley, Mark E. Author's View Adoptive cell transfer immunotherapy against melanoma is highly effective. However, this therapy has seen limited dissemination, mainly due to the complexity and costs of cell expansion protocols. Two bioreactors have recently been described that simplify and streamline the production of individualized cell therapies. Such bioreactors might increase the number of patients that get access to this promising therapeutic modality. Landes Bioscience 2012-11-01 /pmc/articles/PMC3518529/ /pubmed/23243620 http://dx.doi.org/10.4161/onci.21206 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Somerville, Robert P.T. Dudley, Mark E. |
| spellingShingle |
Somerville, Robert P.T. Dudley, Mark E. Bioreactors get personal |
| author_facet |
Somerville, Robert P.T. Dudley, Mark E. |
| author_sort |
Somerville, Robert P.T. |
| title |
Bioreactors get personal |
| title_short |
Bioreactors get personal |
| title_full |
Bioreactors get personal |
| title_fullStr |
Bioreactors get personal |
| title_full_unstemmed |
Bioreactors get personal |
| title_sort |
bioreactors get personal |
| description |
Adoptive cell transfer immunotherapy against melanoma is highly effective. However, this therapy has seen limited dissemination, mainly due to the complexity and costs of cell expansion protocols. Two bioreactors have recently been described that simplify and streamline the production of individualized cell therapies. Such bioreactors might increase the number of patients that get access to this promising therapeutic modality. |
| publisher |
Landes Bioscience |
| publishDate |
2012 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518529/ |
| _version_ |
1611939286227091456 |